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ILDAbstract Aim: In patients with ILD, a static expiratory pressure–volume curve of the lung is gen-
erally shifted downward and rightward and spirometry results reveal reduced vital capacity
(Thompson et al., 1989). However, reduced vital capacity may occur even in patients with obstruc-
tive lung diseases and in other situations, such as chest wall restriction, lung resection, inspiratory
muscle weakness, or poor cooperation with spirometry. In addition, spirometry is sometimes difﬁ-
cult to perform with elderly, cognitively impaired patients, or severe respiratory distress (Kubota
et al., 2009). IOS is a simple, noninvasive method requiring only passive patient cooperation that
allows for the evaluation of lung function through the measurement of both airway resistance
and airway reactance. The aim of this study is to assess the role of IOS in the evaluation of the cases
of interstitial lung diseases.
Methodology: This study included 48 patients with interstitial lung diseases of different causes.
Pulmonary function test by spirometry was done to measure FEV1, FVC, FEV1/FVC, MEF25-75
and pulmonary function test by impulse oscillometry (IOS). We measured R5, R20, X5, RF. Oxy-
gen saturation and 6MWT.
Results: In our study 87% were females. The mean age in our study was 50.75 ± 11.1. Mean X5
was low in ILD denoting restrictive pattern, and there was a negative correlation between
X5 and FEV1/FVC. There was a positive correlation between X5 and 6MWT. The mean R5 was
150.33 ± while mean R20 was 108.33 ± 48.66 this is within normal then this is considered an index
of mild small airways obstruction.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Pulmonary function testing is used to evaluate respiratory
mechanics and physiology in both children and adults with
suspected respiratory diseases. Spirometry is perhaps the most
commonly used pulmonary function test with the advantage of
being readily available in both inpatient and outpatient set-
tings, including many primary care ofﬁces. Lung volume
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requires more-expensive equipment that often requires a dedi-
cated pulmonary function testing laboratory. Simple spirome-
try and body plethysmography often can be performed
successfully in children but may be limited by the child’s ability
to follow directions and provide maximal, reproducible efforts.
Some of the challenges in performing spirometry in younger
children, especially those aged 2–5 years, may have led to this
diagnostic modality being signiﬁcantly underused. Current
data suggest that only 21% of primary care practitioners use
spirometry in the diagnosis of asthma in children [1].
Interstitial lung diseases alter mechanical and gas exchange
properties of the lungs. In general, the hallmarks of interstitial
lung diseases are restrictive changes in pulmonary physiology
(i.e., reduced total lung capacity, reduced residual volume,
decreased static compliance, and a reduced VC, often with
an increased FEV1/FVC ratio), and a reduced diffusing capac-
ity for carbon monoxide (DlCO). A few diseases also manifest
substantial components of airﬂow obstruction [2].
In patients with ILD, a static expiratory pressure–volume
curve of the lung is generally shifted downward and rightward
and spirometry results reveal reduced vital capacity [3]. How-
ever, reduced vital capacity may occur even in patients with
obstructive lung diseases and in other situations, such as chest
wall restriction, lung resection, inspiratory muscle weakness,
or poor cooperation with spirometry. In addition, spirometry
is sometimes difﬁcult to perform with elderly, cognitively
impaired patients, or patients with severe respiratory distress
[4].
The forced oscillation technique is the general name for air-
way mechanic measurements using the noninvasive superim-
position of pressure ﬂuctuations on the airway over the
subject’s normal, quiet, tidal breathing. More than 50 years
ago, FOT was ﬁrst determined by Dubois et al. [5] and has
developed with regard to conﬁguration, standardization, and
application. Impulse oscillometry is one type of FOT. Other
techniques of FOT use only one frequency or change the fre-
quency ‘‘pseudo randomly”. Impulse oscillometry delivers a
regular square wave of pressure 5 times per second, which
has the advantage of generating a larger sample during mea-
surements and emitting a continuous spectrum of frequencies
that may provide a more detailed characterization of respira-
tory function [6]. Impulse oscillometry has been used in adults
as well as in preschool children to identify lung dysfunction,
such as in asthma [7].
IOS is a simple, noninvasive method requiring only passive
patient cooperation that allows for the evaluation of lung func-
tion through the measurement of both airway resistance and
airway reactance [1]. Current IOS procedures are based on
the physiologic concepts of the forced oscillation technique
originally described by Dubois et al. [5] in 1956. IOS usesin [kPa/(l/s)] X5 predicted – 0,15 PX
X5
R5 < 150% predicted Normal I (sl
150% 6 R5< 200% predicted I (slight) II (m
200% 6 R5< 300% predicted II (moderate) III
R5P 300% predicted III (severe) IIIsound waves to rapidly detect airway changes and requires
only normal tidal breathing from the patient [1].
The main advantage of FOT/IOS is that the patient needs
to perform simple tidal breathing maneuvers that require less
effort and co-operation than spirometry, meaning that chil-
dren and the elderly can therefore perform this test easily.
Moreover, it can be performed in patients on ventilators and
also during sleep. One of the most remarkable features of
FOT/IOS in relation to spirometry is that it has much greater
sensitivity to detect peripheral airways obstruction. In most
cases, spirometry does not provide a clear indication of periph-
eral airway obstruction regardless of the information con-
tained in the ﬂow–volume curve and the forced expiratory
ﬂow at 25–75% of forced vital capacity (FEF25–75%). FOT/
IOS are therefore more sensitive instruments to detect small
airway obstruction in patients with asthma and chronic
obstructive pulmonary disease (COPD). More recently, the
within-breath analysis of Rrs and Xrs has been shown to help
differentiate between asthma and COPD and also offer more
useful information about the pathophysiology of asthma and
COPD, which the spirometer does not [8].
IOS is well suited for conditions involving airway obstruc-
tion, but it may not provide deﬁnitive information on restric-
tive states [9] although more research into this area is needed
[1].
Two components of respiratory impedance can be evalu-
ated by forced oscillometry: total respiratory resistance and
reactance [10]. Resistance at low frequency, 5 Hz (R5), indi-
cates total airway resistance and resistance at high frequency,
20 Hz (R20), approximates central airway resistance. The dif-
ference between R5 and R20 (R5  R20) is considered to be an
index of the small airways [11]. Reactance at 5 Hz (X5) is
thought to be reciprocally related to compliance. The resonant
frequency (Fres) is the intermediate frequency at which the
total reactance is 0, and reactance area (AX) is the integrated
low frequency respiratory reactance magnitude (area under the
curve) between 5 Hz and Fres [12]. X5, Fres, and AX have
been proposed for detecting expiratory ﬂow limitations [13–
15].
Interpretation of IOS
R5 total respiratory Resistance – abnormal, if above 150%
predicted
X5 distal capacitive Reactance – abnormal, if below X5 pre-
dicted – 0,15 kPa/(l/s)
Lung function is abnormal, if either R5 or X5 or both
parameters are within the abnormal range. R5 and X5 are
invoked together for the determination of the degree of sever-
ity of disease [15].5> PX5> X5 predicted-0,6
Predicted – 0,3 X5 Predicted – 0,6
ight) II (moderate) III (severe)
oderate) III (severe) III (severe)
(severe) III (severe) III (severe)
(severe) III (severe) III (severe)
Table 3 Minimum, maximum, mean and St deviation results
of the Age, O2 saturation and 6MWT.
Min Max Mean St deviation
Age 29.00 73.00 50.79 11.13
O2 Sat 80.00 98.00 93.04 5.06
6MWT 100.00 355.00 251.50 76.48
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The aim of this study is to evaluate the role of IOS in assess-
ment of the cases of interstitial lung diseases as simple tech-
nique that requires less patient cooperation since those
patients are usually dyspneic and may not be cooperative.
Methodology
This study was conducted in the pulmonary function unit at
the chest department, Kasr Elaini hospital, in the period
August 2015 to March 2016. It included 48 patients with inter-
stitial lung diseases.
Inclusion criteria: 1-Diagnosed patients of interstitial lung
disease.
Exclusion criteria:
1. Any other chest diseases eg COPD, Asthma, Bronchogenic
carcinoma. . . etc
2. Cardiac patients.
The following was performed to each patient:
1. Proper history taking and full clinical examination.
2. Routine laboratory examination including CBC, ESR, Kid-
ney and liver function tests.
3. Measuring oxygen saturation by pulse oximetry and per-
forming 6 MWT.
4. Collagen proﬁle.
5. High resolution CT chest.
6. Some patients were subjected to TBLB or thoracoscopic
lung biopsy for diagnosis.
7. Pulmonary function test by spirometry to measure FEV1,
FVC, FEV1/FVC, and MEF25-75
8. Pulmonary function test by impulse oscillometry (IOS) by
device Master Screen IOS Carefusion Germany 234GmbH
Leibnizstrasse 7 D-97204 Hoechberg SN 737390 IP 20
We measured R5, R20, X5, and RF.
N.B. some patients performed the IOS test were not able to
do spirometry because of their dyspnea were excluded from
this study.Table 1 Sex distribution of the patients.
No Percentage
Male 6 12.5
Female 42 87.5
Total 48 100
Table 2 Diagnosis varieties that were included in this study.
RA-ILD Scleroderma HP
No 16 2 6
% 33.4 4.2 12.5Results and Discussion
In our study it was female dominant as shown in Table 1 were
87% were females which was the same in another study done
by Risa Sokai, Satoru Ito, et al. [16] but in their study they
were considering only patients with RA., while in another
study done by A. Sugiyama [17] males were more than females
in the group of ILD included in their study.
Table 2 shows that more than one third of our cases were
cases of ILD secondary to Rheumatoid arthritis followed by
cases of non speciﬁc interstitial pneumonitis (NSIP) the lower
percentages were those of hypersensitivity pneumonitis (HP),
sarcoidosis and scleroderma.
The mean age in our study was 50.75 ± 11.13 as shown in
Table 3 which matches with the results of the study done by
Elena Semenova [18] 54.46 ± 9.9 year, while the mean age of
ILD patients in the study done by A. Sugiama et al. [17] was
age 65.8 ± 0.9 years.
Table 5 in this study shows a decreased X5 in patients with
ILD which is matching with the study done by A. Sugiama
et al. [17] where the mean X5 was 0.19 ± 0.01 whereas in
our study the mean X5 was – 0.20.
In this study Table 5 shows mean R5 (which refers to small
and large airways) was 150.33 ± which is a mild degree of
obstruction while mean R20 (which refers to large airways
only) was 108.33 ± 48.66 this is within normal then this is con-
sidered an index of small airways obstruction this result was
similar to the results obtained by spirometry in Table 4 that
shows that mean MEF25-75 was 55.25 ± 18.11 that denotes
small airway obstruction too.Sarcoidosis NSIP IPF Total
4 12 8 48
8.2 25 16.7 100
Table 4 Descriptive statistics of the results of the spirometry
study.
Minimum Maximum Mean Std. Deviation
FEV1/FVC 80.00 100.00 88.7917 6.12618
FVC% 22.00 78.00 56.2917 15.33867
FEV1% 24.00 80.00 57.3750 14.74554
MEF25-75 24.00 100.00 55.2500 18.11371
Table 5 Descriptive statistics of the results of the IOS study.
Min Max Mean St deviation
R5% 60.00 306.00 150.3333 64.64085
R20% 46.00 226.00 108.3292 45.66735
X5act .42 .07 .2029 .09406
AAx .12 6.45 2.2271 1.65970
RRf 17.30 29.00 23.4750 3.89569
Table 6 Comparison between categorization of the restriction
degree between spirometry and IOS.
Spirometry IOS
Normal 16
Mild 20 28
Moderate 22 4
Severe 6
Table 8 Comparison between spirometry and IOS in corre-
lation to O2 saturation.
Spirometry O2 sat (Mean
± SD)
IOS O2 sat(Mean
± SD)
Normal 94.7 ± 2.3
Mild 96.5 ± 1.7 91.6 ± 6
Moderate 91.0 ± 4.5 96.5 ± 0.5
Severe 89.0 ± 7.6
Table 9 Comparison between spirometry and IOS in corre-
lation to 6MWT.
Spirometry restriction
6MWT Mean ± SD
IOS restriction 6MWT
Mean ± SD
Normal 261.3 ± 57.6
Mild 289.6 ± 72.6 247.4 ± 80.1
Moderate 245.9 ± 53.4 241.0 ± 28.1
Severe 145.0 ± 58.5
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with ILD there were Rrs values signiﬁcantly higher during the
expiratory phase than during the inspiratory phase
(P< 0.001) at most frequencies Xrs values during a whole
breath, inspiration, and expiration were also signiﬁcantly
increased as a function of frequency in our study 33.4% of
our patients was secondary to RA (see Table 6).
In this study there is a negative correlation between X5 and
FEV1/FVC as shown in Table 7 but it was not statistically sig-
niﬁcant which matches with the restrictive pattern this sup-Table 7 Correlations between different spirometry measured items
FEV1/
FVC
FV
%
Spearman’s
rho
FEV1/FVC Correlation
Coeﬃcient
1.000 .5
Sig. (2-tailed) . .00
FVC% Correlation
Coeﬃcient
.515 1.0
Sig. (2-tailed) .000 .
FEV1% Correlation
Coeﬃcient
.279 .91
Sig. (2-tailed) .055 .00
R 5% Correlation
Coeﬃcient
.078 .11
Sig. (2-tailed) .599 .43
MEF25-
75%
Correlation
Coeﬃcient
.305 .10
Sig. (2-tailed) .035 .49
R 20% Correlation
Coeﬃcient
.108 .2
Sig. (2-tailed) .467 .13
X5 act Correlation
Coeﬃcient
.096 .20
Sig. (2-tailed) .516 .17
O2 SAT% Correlation
Coeﬃcient
.508 .65
Sig. (2-tailed) .000 .00
Highly correlated R20 positive X5 neg.
**Correlation is signiﬁcant at the 0.01 level (2-tailed).
*Correlation is signiﬁcant at the 0.05 level (2-tailed).ports the conclusion in the study done by A. Sugiyama [17]
that suggested that DX5 is a characteristic feature of IOS mea-
surements in ILD patients, which is clearly different from
those in asthma and COPD patients. This within-breath X5
change in ILD might be associated with its severity and phys-
iological abnormality. Also our study showed negative correla-
tion between X5 and FEV1 which is similar to the study done
by Elena Semenova [18] Correlation analysis showed aand IOS measured items.
C FEV1% R 5% MEF25-
75%
R
20%
X5
act
O2 SAT
%
15 .279 .078 .305 .108 .096 .508
0 .055 .599 .035 .467 .516 .000
00 .912 .114 .101 .220 .201 .654
.000 .438 .493 .134 .171 .000
2 1.000 .236 .299 .122 .008 .639
0 . .106 .039 .407 .955 .000
4 .236 1.000 .093 .738 .474 .159
8 .106 . .527 .000 .001 .281
1 .299 .093 1.000 .259 .043 .033
3 .039 .527 . .076 .770 .823
20 .122 .738 .259 1.000 .302 .090
4 .407 .000 .076 . .037 .542
1 .008 .474 .043 .302 1.000 .021
1 .955 .001 .770 .037 . .887
4 .639 .159 .033 090 .021 1.000
0 .000 .281 .823 .542 .887 .
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RV, and FEV1.
In 1968, Fisher et al. [19] showed evidence of increased res-
piratory resistance on FOT in patients with ILD, but the sam-
ple size was small and the FOT analysis was only very basic. In
2009, van Noord et al. [20] reported increased Rrs and reduced
Xrs in patients with advanced ILD, but these values were sim-
ilar to those observed in patients with moderate-to-severe
COPD. The authors therefore commented that the results of
FOT cannot help differentiate between obstructive and restric-
tive disorders.
In 2013, Mori et al. [21] reported that although the total X5
values were lower in ILD and comparable to patients with
COPD, the X5 values were smaller in the expiratory phases
compared with the inspiratory phases in ILD, which is the
reverse of what is found in patients with COPD.
Table 7 shows negative correlation between X5 and FEV1/
FVC. In our study Table 8 showed that there was no correla-
tion between the result of the IOS degree of X5 limitation and
the oxygen saturation of the patients on room air, this point
needs more research to ﬁnd an explanation.
Table 9 shows that the more the degree of restriction as
referred to by the X5 value the lower the distance of 6MWT
but there were no statistically signiﬁcant correlations these
results were the same found by the spirometry test.
Conclusions and recommendations
1. X5 was lower in patients with ILD that denotes restrictive
pattern.
2. There is negative correlation between X5 and FEV1/FVC.
3. There was a positive correlation between X5 and 6MWT.
4. Mean R5 was mildly impaired mean R20 was within nor-
mal denoting small airway obstruction.
5. IOS test was easier to be performed and needed less patient
cooperation whatever the degree of severity of the ILD
disease.
6. Correlation between X5 and oxygen saturation.
7. The IOS and spirometry should not replace each other in
the follow up of the same patient as the degree of the dis-
ease was not the same by both tests.
8. Spirometry is currently more widely adopted and better
studied therefore, interpretation of its results often are
more straight forward to the practitioner yet more studies
are needed on ILD by IOS to encourage its use.Conflict of interest
There is no conﬂict of interest in this study.
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